T1	Participants 12 63	patients at high risk for neutropenic complications
T2	Participants 844 851	Patient
T3	Participants 1425 1432	patient
T4	Participants 1528 1536	Patients
T5	Participants 1691 1698	patient
T6	Participants 1804 1812	patients
